384 related articles for article (PubMed ID: 21502672)
1. Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community.
Onyekwere CA; Ogbera AO; Balogun BO
Ann Hepatol; 2011; 10(2):119-24. PubMed ID: 21502672
[TBL] [Abstract][Full Text] [Related]
2. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
3. Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus.
Olusanya TO; Lesi OA; Adeyomoye AA; Fasanmade OA
Pan Afr Med J; 2016; 24():20. PubMed ID: 27583084
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
Alkassabany YM; Farghaly AG; El-Ghitany EM
Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Liver Enzymes among the Patients with Metabolic Syndrome with or without Non Alcoholic Fatty Liver Disease attending a Tertiary Care Hospital.
Mondal E; Karim MR; Begum A; Hassan K; Noor SM; Khan MM; Khan KH; Ashrafuzzaman SM
Mymensingh Med J; 2023 Apr; 32(2):338-347. PubMed ID: 37002743
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes.
Agarwal AK; Jain V; Singla S; Baruah BP; Arya V; Yadav R; Singh VP
J Assoc Physicians India; 2011 Jun; 59():351-4. PubMed ID: 21751587
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
[TBL] [Abstract][Full Text] [Related]
8. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.
Younossi ZM; Otgonsuren M; Venkatesan C; Mishra A
Metabolism; 2013 Mar; 62(3):352-60. PubMed ID: 22999011
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?
Almobarak AO; Barakat S; Suliman EA; Elmadhoun WM; Mohamed NA; Abobaker IO; Noor SK; Bushara SO; Ahmed MH
Arab J Gastroenterol; 2015 Jun; 16(2):54-8. PubMed ID: 26174761
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of influencing factors and causes of death in elderly residents with non-alcoholic fatty liver disease].
Xu JY; Shao Y; Lu XL; Deng J; Li XL; Shi HT
Zhonghua Gan Zang Bing Za Zhi; 2019 Mar; 27(3):204-209. PubMed ID: 30929337
[No Abstract] [Full Text] [Related]
12. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
Yi M; Chen RP; Yang R; Chen H
Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological survey and risk factor analysis of fatty liver disease of adult residents, Beijing, China.
Yan J; Xie W; Ou WN; Zhao H; Wang SY; Wang JH; Wang Q; Yang YY; Feng X; Cheng J
J Gastroenterol Hepatol; 2013 Oct; 28(10):1654-9. PubMed ID: 23731053
[TBL] [Abstract][Full Text] [Related]
14. Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome.
Hamaguchi M; Takeda N; Kojima T; Ohbora A; Kato T; Sarui H; Fukui M; Nagata C; Takeda J
World J Gastroenterol; 2012 Apr; 18(13):1508-16. PubMed ID: 22509083
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors.
Prasetya IB; Hasan I; Wisnu W; Rumende CM
Acta Med Indones; 2017 Apr; 49(2):91-98. PubMed ID: 28790222
[TBL] [Abstract][Full Text] [Related]
16. [Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions].
Toktogulova NA; Sultanalieva RB; Tuhvatshin RR; Kaliev TK
Ter Arkh; 2023 Jan; 94(12):1361-1366. PubMed ID: 37167179
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease patients attending two metropolitan hospitals in Melbourne, Australia: high risk status and low prevalence.
George ES; Roberts SK; Nicoll AJ; Reddy A; Paris T; Itsiopoulos C; Tierney AC
Intern Med J; 2018 Nov; 48(11):1369-1376. PubMed ID: 29845719
[TBL] [Abstract][Full Text] [Related]
18. A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease.
Bajaj S; Nigam P; Luthra A; Pandey RM; Kondal D; Bhatt SP; Wasir JS; Misra A
Indian J Med Res; 2009 Mar; 129(3):285-92. PubMed ID: 19491421
[TBL] [Abstract][Full Text] [Related]
19. The association of non-alcoholic fatty liver disease and metabolic syndrome in a Chinese population.
Lee SW; Lee TY; Yang SS; Peng YC; Yeh HZ; Chang CS
Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):176-180. PubMed ID: 28381382
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran.
Mansour-Ghanaei F; Joukar F; Mobaraki SN; Mavaddati S; Hassanipour S; Sepehrimanesh M
Diabetes Metab Syndr; 2019; 13(2):1591-1596. PubMed ID: 31336526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]